Drug Shortage Report for CYMBALTA

Last updated on 2024-10-09 History
Report ID 220042
Drug Identification Number 02301490
Brand name CYMBALTA
Common or Proper name Duloxetine hydrochloride delayed release capsules
Company Name ELI LILLY CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) DULOXETINE
Strength(s) 60MG
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL
Packaging size Carton containing 28 capsules in blister packaging
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2024-04-19
Actual start date 2024-04-12
Estimated end date Unknown
Actual end date 2024-09-25
Shortage status Resolved
Updated date 2024-10-09
Company comments Product is discontinued. Report ID 238865. We ask that you contact your healthcare provider. For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments
Tier 3 Status No
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2024-10-09 French Compare
v12 2024-10-09 English Compare
v11 2024-09-27 French Compare
v10 2024-09-27 English Compare
v9 2024-09-05 French Compare
v8 2024-09-05 English Compare
v7 2024-04-13 English Compare
v6 2024-04-12 French Compare
v5 2024-04-12 English Compare
v4 2024-03-13 French Compare
v3 2024-03-13 English Compare
v2 2024-02-20 French Compare
v1 2024-02-20 English Compare

Showing 1 to 13 of 13